InfuSystem (INFU) CFO adds 2,064 shares in open-market purchase

Rhea-AI Filing Summary

InfuSystem Holdings executive Barry G. Steele, Executive VP and CFO, bought 2,064 shares of common stock in open-market purchases at a weighted average price of $9.16 per share. A footnote notes the total holdings also reflect 1,359 shares recently acquired through the company’s Employee Stock Purchase Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Steele Barry G

(Last) (First) (Middle)

C/O INFUSYSTEM HOLDINGS, INC.

3851 WEST HAMLIN ROAD

(Street)

ROCHESTER HILLS MI 48309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								85,936(1)	D
Common Stock	03/02/2026	03/02/2026	P		2,064	A	$9.16(2)	88,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This total includes an additional 1,359 shares acquired recently through the Company's Employee Stock Purchase Plan

2. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Kevin Whitman, Attorney-in-Fact for Barry G. Steele	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did InfuSystem (INFU) report for Barry G. Steele?

InfuSystem reported that Executive VP and CFO Barry G. Steele purchased 2,064 shares of common stock. The transaction was an open-market purchase, indicating he used personal funds to increase his direct ownership in the company’s shares at prevailing market prices.

How many InfuSystem (INFU) shares did the CFO buy and at what price?

Barry G. Steele bought 2,064 InfuSystem common shares at a weighted average price of $9.16 per share. The filing notes the purchase occurred in multiple transactions, with the reported price representing the average across those separate trades executed in the market.

What role does Barry G. Steele hold at InfuSystem (INFU)?

Barry G. Steele serves as Executive Vice President and Chief Financial Officer of InfuSystem. As CFO, he is a key officer responsible for the company’s financial management, and his personal share purchases are monitored through Form 4 insider trading disclosures filed with regulators.

Were there additional InfuSystem (INFU) shares acquired through an employee plan?

Yes. A footnote explains that the reported total holdings include an additional 1,359 shares recently acquired through InfuSystem’s Employee Stock Purchase Plan. This indicates part of the CFO’s ownership increase came from ongoing participation in the company’s employee share purchase program.

What does the weighted average price mean in this InfuSystem (INFU) Form 4?

The weighted average price of $9.16 per share reflects that the 2,064 InfuSystem shares were purchased in multiple trades at different prices. The filing states the insider will provide full details of each separate purchase price and share amount to interested parties upon request.

Does the InfuSystem (INFU) Form 4 mention any sales by the CFO?

No sales are reported. The Form 4 transaction summary shows one open-market purchase of 2,064 shares and no sales, resulting in a net buy position. This indicates the only reported trading activity for the period increased the CFO’s common stock ownership.